MCT-1/SLC16A1 is regulated by Wnt/β-catenin signaling in colon cancer cells. MCT-1 can export lactate, pyruvate as well as a glycolysis-targeting cancer drug, 3-bromopyruvate (3-BP). This evidence concerns the gene SLC16A1 and colonic neoplasm.